Amgen Inc. Inventory, Finished Goods, Net of Reserves
Amgen Inc. (AMGN) had Inventory, Finished Goods, Net of Reserves of $1.67 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-05
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $1.67B.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $1.71B.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $1.89B.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $1.84B.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $1.67B 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.71B 10-Q · filed 2026-05-01 |
| 2025-12-31 | $1.89B 10-Q · filed 2026-08-05 |
| 2025-09-30 | $1.84B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.04B 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.93B 10-Q · filed 2025-05-02 |
| 2024-12-31 | $2.06B 10-K · filed 2026-02-13 |
| 2024-09-30 | $2.23B 10-Q · filed 2024-10-31 |
| 2024-06-30 | $2.63B 10-Q · filed 2024-08-07 |
| 2024-03-31 | $2.53B 10-Q · filed 2024-05-03 |
| 2023-12-31 | $2.78B 10-K · filed 2025-02-14 |
| 2023-09-30 | $1.19B 10-Q · filed 2023-10-31 |
| 2023-06-30 | $1.07B 10-Q · filed 2023-08-04 |
| 2023-03-31 | $1.13B 10-Q · filed 2023-04-28 |
| 2022-12-31 | $1.00B 10-K · filed 2024-02-14 |
| 2022-09-30 | $1.03B 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.01B 10-Q · filed 2022-08-05 |
| 2022-03-31 | $1.08B 10-Q · filed 2022-04-28 |
| 2021-12-31 | $1.07B 10-K · filed 2023-02-09 |
| 2021-09-30 | $1.17B 10-Q · filed 2021-11-03 |
| 2021-06-30 | $1.03B 10-Q · filed 2021-08-04 |
| 2021-03-31 | $949.00M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $970.00M 10-K · filed 2022-02-16 |
| 2020-09-30 | $895.00M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $1.00B 10-Q · filed 2020-07-29 |
| 2020-03-31 | $1.04B 10-Q · filed 2020-05-01 |
| 2019-12-31 | $999.00M 10-K · filed 2021-02-09 |
| 2019-09-30 | $996.00M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $1.09B 10-Q · filed 2019-07-31 |
| 2019-03-31 | $970.00M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $1.02B 10-K · filed 2020-02-12 |
| 2018-09-30 | $958.00M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $1.06B 10-Q · filed 2018-07-27 |
| 2018-03-31 | $1.05B 10-Q · filed 2018-04-25 |
| 2017-12-31 | $934.00M 10-K · filed 2019-02-13 |
| 2017-09-30 | $1.01B 10-Q · filed 2017-10-26 |
| 2017-06-30 | $1.11B 10-Q · filed 2017-07-26 |
| 2017-03-31 | $1.16B 10-Q · filed 2017-04-27 |
| 2016-12-31 | $912.00M 10-K · filed 2018-02-13 |
| 2016-09-30 | $1.10B 10-Q · filed 2016-10-28 |
| 2016-06-30 | $956.00M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $783.00M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $705.00M 10-K · filed 2017-02-14 |
| 2015-09-30 | $962.00M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $1.03B 10-Q · filed 2015-08-05 |
| 2015-03-31 | $1.19B 10-Q · filed 2015-04-27 |
| 2014-12-31 | $898.00M 8-K · filed 2016-10-31 |
| 2014-09-30 | $988.00M 10-Q · filed 2014-10-29 |
| 2014-06-30 | $916.00M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $869.00M 10-Q · filed 2014-04-30 |
| 2013-12-31 | $738.00M 10-K · filed 2015-02-19 |
| 2013-09-30 | $813.00M 10-Q · filed 2013-10-29 |
| 2013-06-30 | $863.00M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $876.00M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $829.00M 10-K · filed 2014-02-24 |
| 2012-09-30 | $816.00M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $752.00M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $711.00M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $524.00M 10-K · filed 2013-02-27 |
| 2011-09-30 | $482.00M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $520.00M 10-Q · filed 2011-08-08 |
| 2011-03-31 | $518.00M 10-Q · filed 2011-05-10 |
| 2010-12-31 | $512.00M 10-K · filed 2012-02-29 |
| 2010-09-30 | $455.00M 10-Q · filed 2010-11-08 |
| 2010-06-30 | $464.00M 10-Q · filed 2010-08-09 |
| 2009-12-31 | $440.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |